Jaka jest cena za Adcock Ingram Holdings Limited (AIP)

Cena za Adcock Ingram Holdings Limited (AIP) wynosi $4.38

Jaka jest kapitalizacja rynkowa dla Adcock Ingram Holdings Limited (AIP)

Kapitalizacja rynkowa dla Adcock Ingram Holdings Limited (AIP) wynosi $668.68M

Przychody Adcock Ingram Holdings Limited (AIP)

Adcock Ingram Holdings Limited, established in 1890 and headquartered in Midrand, South Africa, operates as a global manufacturer, marketer, and distributor of diverse healthcare products. Its international footprint extends across South Africa, the United States, Canada, the United Kingdom, broader Europe, and other international regions. The company offers a comprehensive product portfolio, including over-the-counter (OTC) remedies, prescription medications, consumer health goods, and specialized medical instrumentation and surgical supplies. Its extensive pharmaceutical range covers numerous therapeutic classes, such as women's health, cannabidiol applications, antiretroviral treatments, dermatology, central nervous system disorders, respiratory conditions, ophthalmology, generic medicines, cardiovascular health, pain relief, gastroenterology, energy and immunity support (including colds and flu remedies, vitamins, minerals, and food/nutrition supplements), personal care, feminine hygiene, digestive well-being, allergy management, baby care, and cough solutions. Beyond its general healthcare offerings, Adcock Ingram also manufactures and supplies essential hospital and critical care products, such as intravenous solutions, renal dialysis systems, and blood collection supplies. The company serves both private and public sectors within the healthcare industry.

Rok	Przychody	Zmień
Za mało danych dla podanych dat.

Rok

Przychody

Zmień

Za mało danych dla podanych dat.

Firma	Przychody	Różnica w przychodach	Kraj
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Firma

Przychody

Różnica w przychodach

Kraj